chrX-41853205-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong
The NM_001367721.1(CASK):c.82C>T(p.Arg28*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
CASK
NM_001367721.1 stop_gained
NM_001367721.1 stop_gained
Scores
2
2
1
Clinical Significance
Conservation
PhyloP100: 2.52
Genes affected
CASK (HGNC:1497): (calcium/calmodulin dependent serine protein kinase) This gene encodes a calcium/calmodulin-dependent serine protein kinase. The encoded protein is a MAGUK (membrane-associated guanylate kinase) protein family member. These proteins are scaffold proteins and the encoded protein is located at synapses in the brain. Mutations in this gene are associated with FG syndrome 4, intellectual disability and microcephaly with pontine and cerebellar hypoplasia, and a form of X-linked intellectual disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.971 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PP5
Variant X-41853205-G-A is Pathogenic according to our data. Variant chrX-41853205-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 158086.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-41853205-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CASK | NM_001367721.1 | c.82C>T | p.Arg28* | stop_gained | 2/27 | ENST00000378163.7 | NP_001354650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASK | ENST00000378163.7 | c.82C>T | p.Arg28* | stop_gained | 2/27 | 5 | NM_001367721.1 | ENSP00000367405.1 |
Frequencies
GnomAD3 genomes AF: 0.00000902 AC: 1AN: 110890Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33148
GnomAD3 genomes
AF:
AC:
1
AN:
110890
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33148
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1083325Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 349865
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1083325
Hom.:
Cov.:
27
AF XY:
AC XY:
0
AN XY:
349865
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000902 AC: 1AN: 110890Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33148
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
110890
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33148
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Syndromic X-linked intellectual disability Najm type Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Aug 14, 2023 | This variant was identified as de novo. Criteria applied: PVS1, PS2_MOD, PS4_MOD, PM2_SUP. - |
Pathogenic, criteria provided, single submitter | clinical testing | Mendelics | Mar 24, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 27, 2014 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 15, 2020 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 32696595, 24781210, 28944139) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2022 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2019 | The p.R28* pathogenic mutation (also known as c.82C>T), located in coding exon 2 of the CASK gene, results from a C to T substitution at nucleotide position 82. This changes the amino acid from an arginine to a stop codon within coding exon 2. This mutation was reported as de novo in a female with intellectual disability, neurosensory deafness, microcephaly, and later onset infantile spasms (Michaud JL et al. Hum. Mol. Genet., 2014 Sep;23:4846-58). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
FG syndrome 4 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | May 22, 2022 | The variant is not observed in the gnomAD v2.1.1 dataset. Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported to be associated with CASK related disorder (ClinVar ID: VCV000158086).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Intellectual disability, CASK-related, X-linked Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 27, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 158086). This premature translational stop signal has been observed in individual(s) with clinical features of CASK-related conditions (PMID: 24781210). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg28*) in the CASK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CASK are known to be pathogenic (PMID: 19165920, 20029458, 21954287, 22452838, 22709267). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
0.87, 0.95, 0.87, 0.95, 0.95
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at